Eight of these eleven tumors had an activating BRAF or NRAS mutation, and although BRAFV600E has been associated with the internalization of HLA-ABC from the cell surface28, we did not detect any genotype-associated differences in the cell surface expression of HLA-ABC in 31 melanoma tumors (Supplementary Fig. 7A). This evidence concerns the gene NRAS and melanoma.